首页> 外国专利> BLOCKADE OF PROTEIN C ACTIVATION REDUCES MICROVASCULAR SURGICAL BLOOD LOSS.

BLOCKADE OF PROTEIN C ACTIVATION REDUCES MICROVASCULAR SURGICAL BLOOD LOSS.

机译:蛋白质C活化的阻滞减少了微血管外科血液的损失。

摘要

It has been discovered that by temporarily blocking one or more natural anticoagulants, such as the activation of intrinsic protein C, subsequent surgical blood loss from a microvascular surgical or traumatic wound can be substantially reduced. Other natural anticoagulants include thrombomodulin, antithrombin III, and tissue factor inhibitor pathway. The effects of protein C blockade were compared to the standard therapy, topical thrombin, and to the experimental topical agent, tissue thromboplastin. Domestic pigs were blindly pretreated with intravenous HPC4 or saline then underwent partial-thickness skin graft harvesting to create a reproducible microvascular wound. It was found that blocking the activation of protein C significantly reduces surgical blood loss compared to saline control animals. Intravenous HPC4 performed equally as well as topical thrombin or tissue thromboplastin. In addition, topical thrombin acted synergistically with HPC4 to further reduce blood.
机译:已经发现,通过暂时阻断一种或多种天然抗凝剂,例如内在蛋白C的活化,可以从微血管外科手术或创伤性伤口中减少随后的手术失血量。其他天然抗凝剂包括血栓调节蛋白,抗凝血酶III和组织因子抑制剂途径。将蛋白C阻断的作用与标准疗法局部凝血酶和实验性局部促凝血酶原组织凝血活酶进行了比较。用静脉注射HPC4或盐水对家猪进行盲目预处理,然后收获部分厚度的皮肤移植物,以产生可再现的微血管伤口。已经发现,与盐水对照动物相比,阻断蛋白C的活化显着减少了手术失血。静脉内HPC​​4的表现与局部凝血酶或组织凝血活酶相同。此外,局部凝血酶与HPC4协同作用,进一步减少血液。

著录项

  • 公开/公告号EP0651655A4

    专利类型

  • 公开/公告日1996-05-29

    原文格式PDF

  • 申请/专利权人 OKLAHOMA MEDICAL RESEARCH FOUNDATION;

    申请/专利号EP19930918369

  • 发明设计人 COMP PHILIP C.;

    申请日1993-07-23

  • 分类号A61K39/00;A61K35/14;A61K39/395;C07K14/00;C07K15/28;C07K15/28;

  • 国家 EP

  • 入库时间 2022-08-22 03:47:29

相似文献

  • 专利
  • 外文文献
  • 中文文献
获取专利

客服邮箱:kefu@zhangqiaokeyan.com

京公网安备:11010802029741号 ICP备案号:京ICP备15016152号-6 六维联合信息科技 (北京) 有限公司©版权所有
  • 客服微信

  • 服务号